PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 16, 2026Biomedical Materials1 citationsOpen Access

Enzymatic cell-surface engineering with glycocalyx mimicking anti-oxidant and anti-inflammatory sulfated polymers for protection against inflammatory vascular injury

View Full Paper
HLHaiming D. LuoMRMd Mohosin RanaPNPeyman Malek Mohammadi Nouri

Key Points

  • This study aims to develop a cell surface engineering approach using sulfated polymers to protect endothelial cells from inflammatory vascular injury.
  • End functionalized sulfated polymers (LPGS-Q) were enzymatically ligated onto endothelial surfaces using transglutaminase.
  • Effects on oxidative stress and inflammatory responses were evaluated through in vitro experiments and a vascular injury mouse model.
  • Macrophage responses and endothelial cell adhesion to immune cells were assessed for inflammation modulation.
  • LPGS-Q-modified endothelial cells scavenged reactive oxygen species and reduced IL-6 secretion during inflammation.
  • Endothelial cells showed reduced adhesion of activated immune cells, indicating decreased inflammation.
  • In a mouse model, LPGS-Q treatment led to increased IL-10 levels and reduced chemokine production, suggesting local immune modulation.

Abstract

The endothelial glycocalyx is among the earliest cellular components disrupted during inflammatory vascular injury, where oxidative stress and inflammatory signaling drive endothelial dysfunction. Current therapeutic strategies remain limited in their ability to provide localized protection directly at the endothelial surface. This study presents a cell surface engineering approach using end functionalized synthetic sulfated polymers to mitigate oxidative stress and attenuate inflammatory responses on endothelial surfaces. Linear polyglycerol sulfates modified one-end with a Q-tagged peptide (LPGS-Q) was enzymatically ligated onto cell surfaces via guinea pig liver transglutaminase (gtTGase), forming an endothelial cell glycocalyx mimicking interface with antioxidant and anti-inflammatory activity that emulates key heparan sulfate-like functions. In vitro, LPGS-Q-modified endothelial cells scavenged reactive oxygen species, preserved glycocalyx integrity, reduced IL-6 secretion under TNF-α stimulation, and maintained viability under oxidative stress. LPGS-Q-treated macrophages also exhibited suppressed TNF-α release following M1 polarization, and surface-engineered endothelial cells showed reduced adhesion of activated peripheral blood mononuclear cells, indicating protection against immune-mediated injury. In a vascular injury mouse transplantation model, LPGS-Q treatment was associated with reduced Th1-associated chemokines and a modest increase in IL-10, suggesting systemic immunomodulatory potential. Although histological injury and immune infiltration at day 7 were comparable between groups, CD31 staining showed increased endothelial-associated area in LPGS-Q treated grafts, consistent with decreased endothelial damage or increased endothelial protection. Together, these data support LPGS-Q-based surface engineering as a modular strategy for localized endothelial protection relevant to inflammatory vascular injury states characterized by oxidative stress and glycocalyx disruption, although its in vivo effects are modest under the current experimental conditions.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Luo et al. (2026) studied this question.

synapsesocial.com/papers/6a080969a487c87a6a40b458https://doi.org/10.1088/1748-605x/ae6d62
Ask AI
Helpful
Bookmark
Share
View Full Paper